Category Archives: Blog

Frontida BioPharm, Inc. Names Dr. Ralph Landau President

Frontida BioPharm, Inc. Names Dr. Ralph Landau President

Frontida Biopharm, Inc is pleased to announce that Dr. Ralph Landau has been appointed to the role of President of Frontida Biopharm, Inc. He will be responsible the operations in both the United States and China.

AdaptDose™ an Innovative platform

AdaptDose™, The innovation in drug development, that reduces development time by up to 30%

Frontida’s AdaptDose™ technology platform provides a tool that can eliminate the need to reformulate after Phase I and overcomes several technical hurdles in the development and scale up of (1) new molecules, (2) binary and tertiary mixtures of active ingredients, zero and first order drug release matrices, or (3) scalable clinical trial materials used in dose ranging or adaptive dose clinical studies.